-
In a decision more than 10 years in the making, a U.S. Federal District judge ruled April 5, 2013, that the Food and Drug Administration (FDA) must lift age and point-of-sale restrictions on Plan B One-Step emergency contraception (EC) within 30 days.
-
A new Agency for Healthcare Research and Quality (AHRQ) review of available evidence reveals that women who have problematic irregular or heavy cyclic menstrual bleeding have several safe and effective nonsurgical treatment options.1
-
-
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
-
-
Add new research to your clinics protocols: The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia.
-
Check your clinics patient files for the last year. How many visits were made by males? According to 2010 data from the Agency for Healthcare Research and Quality, just over half of U.S. men (57%) see a doctor, nurse practitioner, or physician assistant for routine care, compared to nearly three-quarters (74%) of women.
-
Combined oral contraceptives should be sold over the counter in drugstores without a providers prescription, according to a new committee opinion issued by the American College of Obstetricians and Gynecologists (ACOG).
-
Young people between ages 13-24 represent more than a quarter of new HIV infections each year, and 60% of youth living with HIV are unaware they are infected, according to a new report from the Centers for Disease Control and Prevention (CDC).
-
Implementation of the Patient Protection and Affordable Care Act of 2010 (ACA) will be an ongoing process, but one major change that already has begun is the expansion of community health centers (CHCs).